top of page

BioSpectrum Asia I Our approach to managing the side effects of cancer therapy has evolved

By Dr. Manbeena Chawla

June 2022

Although there has been tremendous progress in discovering and developing new therapies to treat cancer patients, innovation in treating or preventing the side effects has lagged in comparison. The number of patients with cancer is growing, and patients continue to struggle with treatment side effects, leading to dose reduction or discontinuation of cancer therapeutics. This creates an opportunity for a new generation of cancer supportive agents to help an underserved population of patients in need. To find out more in this regard, BioSpectrum Asia spoke to Mike McCullar, Chief Executive Officer, OnQuality Pharmaceuticals in detail. The company has operations in the US and China

Full text here:


bottom of page